Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Pain management in the pharmacy: new Nice guideline for chronic pain

Yousaf Ahmad – chief pharmacist at the Practice Plus Group and the UK Clinical Pharmacy Association pain group educational lead – discusses the new National Institute for health and Care Excellence (Nice) guideline for the management of chronic pain, and how pharmacy teams can identify patients presenting in the pharmacy with acute pain.

You can listen to the podcast below. Alternatively, subscribe to C+D's podcasts by searching “Chemist+Druggist podcast” on your preferred app or on Soundcloud.

 

The new Nice guideline has provided “a clearer definition of chronic pain”, Mr Ahmad tells C+D’s clinical and custom content editor Naimah Callachand. By focusing on patient-centred assessments, the guideline also addresses the psycho-social impact of pain and has “provided more intel for healthcare professionals and those at the pharmacy counter to look at more holistic assessment of the individual [in the management of pain]”, he says.

Mr Ahmad also discusses what the new guideline mean for the management of acute pain in the pharmacy. “Acute pain not managed well can result in chronic pain”, and “choosing the right therapy is vitally important”, he emphasises. The guideline focuses on “using the right early treatment” for the aggressive management of acute pain, he adds.

Mr Ahmed says pharmacy teams have a central role to play in pain management by asking the right questions during the consultation to identify the type of pain the patient is suffering from and referring patients for further advice if they present with any red flag symptoms. “Pain is subjective”, he says, therefore it is important that pharmacy teams “tailor each consultation and treatment recommendations to the individual patient”.

This podcast has been developed in partnership with Reckitt.

Topics

         
Registrant member of the Assurance and Appointments Committee 
Nationwide
£ Renumeration

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD135386

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel